Abstract
States that have legalized cannabis for medicinal or retail use have noted increases in emergency department (ED) visits associated with cannabis-associated harms. However, most studies are retrospective and identify cannabis-related visits using diagnosis codes or THC-positive urine drug immunoassays. These identification methods are limited. ICD codes are infrequently used in adult ED cases of exposure to drugs of abuse and clinicians may not explicitly document diagnosis of drug use, even when highly suspected or confirmed by patients.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Academic emergency medicine : official journal of the Society for Academic Emergency Medicine
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
